PUBLICATIONS · 22975218
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2012 Nov
- First author
- Lipton A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Eur J Cancer. 2013 Jun;49(9):2264-5. doi: 10.1016/j.ejca.2013.02.036.
- note
- Source null
- related pmid
- 23541567
- relationship
- Comment in
- citation
- Eur J Cancer. 2013 Jun;49(9):2266-8. doi: 10.1016/j.ejca.2013.02.037.
- note
- Source null
- related pmid
- 23578571
- relationship
- Comment in
- citation
- Orthopade. 2014 Feb;43(2):182.
- note
- Source null
- related pmid
- 24693556
- relationship
- Comment in
Authors and identifiers
- name
- Lipton A
- type
- Author
- name
- Fizazi K
- type
- Author
- name
- Stopeck AT
- type
- Author
- name
- Henry DH
- type
- Author
- name
- Brown JE
- type
- Author
- name
- Yardley DA
- type
- Author
- name
- Richardson GE
- type
- Author
- name
- Siena S
- type
- Author
- name
- Maroto P
- type
- Author
- name
- Clemens M
- type
- Author
- name
- Bilynskyy B
- type
- Author
- name
- Charu V
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Lipton A
- type
- Author
- name
- Fizazi K
- type
- Author
- name
- Stopeck AT
- type
- Author
- name
- Henry DH
- type
- Author
- name
- Brown JE
- type
- Author
- name
- Yardley DA
- type
- Author
- name
- Richardson GE
- type
- Author
- name
- Siena S
- type
- Author
- name
- Maroto P
- type
- Author
- name
- Clemens M
- type
- Author
- name
- Bilynskyy B
- type
- Author
- name
- Charu V
- type
- Author
- bibliography ids
- nci-bib-220e00548753043bc3235362
- book metadata
- content sha256
- 2d4b4c2fbb401ef6e2a300c5373d150eb60da4194dbce37630ec6b817931b201
- document type
- citation
- dois
- 10.1016/j.ejca.2012.08.002
- electronic publication date
- display
- 2012 Sep 10
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22975218
- immutable id
- pubmed:22975218@2d4b4c2fbb401ef6e2a300c5373d150eb60da4194dbce37630ec6b817931b201
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- 16
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 3082-92
- volume
- 48
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Eur J Cancer. 2013 Jun;49(9):2264-5. doi: 10.1016/j.ejca.2013.02.036.
- note
- Source null
- related pmid
- 23541567
- relationship
- Comment in
- citation
- Eur J Cancer. 2013 Jun;49(9):2266-8. doi: 10.1016/j.ejca.2013.02.037.
- note
- Source null
- related pmid
- 23578571
- relationship
- Comment in
- citation
- Orthopade. 2014 Feb;43(2):182.
- note
- Source null
- related pmid
- 24693556
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 22975218
- provenance
- batch id
- 1e3045de9f47a5ccd566
- provider
- NCBI PubMed ESummary
- record sha256
- 81309701089489b237b3d4dc122daf581ab236b4bf681c6df4e084c7c6d3d0ce
- response sha256
- 0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
- retrieved at
- 2026-09-09T23:46:50.128287+00:00
- publication date
- display
- 2012 Nov
- precision
- month
- year
- 2012
- publication types
- Journal Article
- Meta-Analysis
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials.
Preserved source evidence · Not medical advice
Triangle